


| Revenue | $10 - $100 million See Exact Annual Revenue |
|---|---|
| Employees | 100 - 500Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Additional NAICS Codes | 541711 Research & Development in Biotechnology |
| Address | 400 Fairview Ave North 9th Floor Seattle, WA 98109 |
| Chinook Therapeutics | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $10 - $100 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Chinook Therapeutics P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| C Medicines, medicinal drugs, pharmaceutical drugs, therapeutic pharmaceuticals, pharmaceutical preparations, biologics, biological preparations and therapeutic agents, all for use in the prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions | 03/12/2021 |
| CHINOOK Medicines, drugs, therapeutic pharmaceuticals, pharmaceutical preparations, biologics, biologic preparations and therapeutic agents, all for use by prescription in the prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions, and not distributed in first aid kits | 07/30/2020 |
| CHINOOK THERAPEUTICS Medicines, drugs, therapeutic pharmaceuticals, pharmaceutical preparations, biologics, biologic preparations and therapeutic agents, all for use by prescription in the prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions, and not distributed in first aid kits | 07/30/2020 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| FRED HUTCHINSON CANCER CENTER | Seattle, WA | 100 |
| ADAPTIVE BIOTECHNOLOGIES | Seattle, WA | 14 |
| ALLEN INSTITUTE | Seattle, WA | 13 |
| JUNO THERAPEUTICS | Seattle, WA | 13 |
| SANA BIOTECHNOLOGY | Seattle, WA | 9 |
| ULTRA SAFE NUCLEAR | Seattle, WA | 5 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |